Search results

Showing 1 – 50 of 84 results.
Curated

Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 1998 (ICPSR 2826)

Released/updated on: 1999-11-10
Geographic coverage: United States
Time period: 1998-01-01--1998-12-31
The Arrestee Drug Abuse Monitoring (ADAM) Program measures levels of and trends in drug use among persons arrested and booked in the United States. The ADAM Program is a redesigned version of the Drug Use Forecasting (DUF) Program (DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 [ICPSR 9477]), upgraded methodologically and expanded to include 35 cities. The data address the following topics: (1) types of drugs used by arrestees (based on self-reports and urinalysis), (2) self-reported dependency on drugs, (3) self-reported need for alcohol/drug treatment, (4) the relationship between drug use and certain types of offenses, and (5) the relationship between self-reported indicators of drug use and indicators of drug use based on urinalysis. Participation in the project is voluntary, and all information collected from the arrestees is anonymous and confidential. The data include the arrestee's age, race, gender, educational attainment, marital status, and the charge at the time of booking. The recently modified ADAM/DUF interview instrument (used for part of the 1995 DUF data and all of the DUF 1996, DUF 1997, and ADAM 1998 data) also collected information about the arrestee's self-reported use of 15 drugs. For each drug type, arrestees were asked whether they had ever used the drug, the age at which they first used the drug, whether they had used the drug within the past three days, how many days they had used the drug within the past month, whether they had ever needed or felt dependent on the drug, and whether they were dependent on the drug at the time of the interview. Data from the new interview instrument also included information about whether arrestees had ever injected drugs and whether they were influenced by drugs when they allegedly committed the crimes for which they were arrested. The data also include information about whether the arrestee had been to an emergency room for drug-related incidents and whether he or she had prior arrests in the last 12 months. Data that continue to be collected with the new version of the ADAM/DUF interview provide information about arrestees' histories of drug/alcohol treatment, including whether they ever received drug/alcohol treatment and whether they needed drug/alcohol treatment. As part of the ADAM program, arrestees were asked to provide a urine specimen, which was screened for the presence of the following ten drug types: marijuana, opiates, cocaine, PCP, methadone, benzodiazepines (Valium), methaqualone, propoxyphene (Darvon), barbiturates, and amphetamines (positive test results for amphetamines were confirmed by gas chromatography).
Curated

Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 1999 (ICPSR 2994)

Released/updated on: 2006-03-30
Geographic coverage: United States
Time period: 1999-01-01--1999-12-31
The Arrestee Drug Abuse Monitoring (ADAM) Program, the successor to the Drug Use Forecasting (DUF) Program (DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 [ICPSR 9477]), measures levels of and trends in drug use among persons arrested and booked in 35 sites across the United States. The data address the following topics: (1) types of drugs used by arrestees (based on self-reports and urinalysis), (2) self-reported dependency on drugs, (3) self-reported need for alcohol/drug treatment, (4) the relationship between drug use and certain types of offenses, and (5) the relationship between self-reported indicators of drug use and indicators of drug use based on urinalysis. Participation in the project is voluntary, and all information collected from the arrestees is anonymous and confidential. The data include the arrestee's age, race, gender, educational attainment, marital status, and the charge at the time of booking. The modified ADAM/DUF interview instrument (used for part of the 1995 data and all of the 1996, 1997, 1998, and 1999 data) also collected information about the arrestee's use of 15 drugs, including recent and past use (e.g., 3-day and 30-day drug use), age at first use, and whether the arrestee had ever been dependent on drugs. As part of the ADAM program, arrestees were asked to provide a urine specimen, which was screened for the presence of ten drugs, including marijuana, opiates, cocaine, PCP, methadone, benzodiazepines (Valium), methaqualone, propoxyphene (Darvon), barbiturates, and amphetamines (positive test results for amphetamines were confirmed by gas chromatography).
Curated

Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2000 (ICPSR 3270)

Released/updated on: 2006-03-30
Geographic coverage: United States
Time period: 2000-01-01--2000-12-31
Beginning in 1996, the National Institute of Justice (NIJ) initiated a major redesign of its multisite drug-monitoring program, the Drug Use Forecasting (DUF) system (DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 [ICPSR 9477]). The program was retitled Arrestee Drug Abuse Monitoring (ADAM) (see ARRESTEE DRUG ABUSE MONITORING (ADAM) PROGRAM IN THE UNITED STATES, 1998 [ICPSR 2628] and 1999 [ICPSR 2994]). ADAM extended DUF in the number of sites and improved the quality and generalizability of the data. The redesign was fully implemented in all sites beginning in the first quarter of 2000. The ADAM program implemented a new and expanded adult instrument in the first quarter of 2000, which was used for both the male (Part 1) and female (Part 2) data. The juvenile data for 2000 (Part 3) used the juvenile instrument from previous years. The ADAM program also moved to probability-based sampling for the adult male population during 2000. Therefore, the 2000 adult male sample includes weights, generated through post-sampling stratification of the data. The shift to sampling of the adult male population in 2000 required that all 35 sites move to a common catchment area, the county. The core instrument for the adult cases was supplemented by a facesheet, which was used to collect demographic and charge information from official records. Core instruments were used to collect self-report information from the respondent. Both the adult and juvenile instruments were administered to persons arrested and booked on local or state charges relevant to the jurisdiction (i.e., not federal or out-of-county charges) within the past 48 hours. At the completion of the interview the arrestee was asked to voluntarily provide a urine specimen. An external lab used the Enzyme Multiplied Immunoassay Testing (EMIT) protocols to test for the presence of ten drugs or metabolites of the drug in the urine sample. All amphetamine positives were confirmed by gas chromatography/mass spectrometry (GC/MS) to determine whether methamphetamine was used. For the adult data, variables from the facesheet include arrest precinct, ZIP code of arrest location, ZIP code of respondent's address, respondent's gender and race, three most serious arrest charges, sample source (stock, flow, other), interview status (including reason the individual selected in the sample was not interviewed), language of instrument used, and the number of hours since arrest. Demographic information from the core instrument includes respondent's age, ethnicity, residency, education, employment, health insurance coverage, marital status, housing, and telephone access. Variables from the calendar provide information on inpatient and outpatient substance abuse treatment, inpatient mental health treatment, arrests and incarcerations, heavy alcohol use, use of marijuana, crack/rock cocaine, powder cocaine, heroin, methamphetamine, and other drug (ever and previous 12 months), age of first use of the above six drugs and heavy alcohol use, drug dependency in the previous 12 months, characteristics of drug transactions in past 30 days, use of marijuana, crack/rock cocaine, powder cocaine, heroin, and methamphetamine in past 30 days, 7 days, and 48 hours, heavy alcohol use in past 30 days, and secondary drug use of 15 other drugs in the past 48 hours. Urine test results are provided for 11 drugs -- marijuana, cocaine, opiates, phencyclidine (PCP), benzodiazepines (Valium), propoxyphene (Darvon), methadone, methaqualone, barbiturates, amphetamines, and methamphetamine. The adult data files include several derived variables. The male data also include four sampling weights, and stratum identifications and percents. For the juvenile data, demographic variables include age, race, sex, educational attainment, employment status, and living circumstances. Data also include each juvenile arrestee's self-reported use of 15 drugs (alcohol, tobacco, marijuana, powder cocaine, crack, heroin, PCP, amphetamines, barbiturates, quaaludes, methadone, crystal methamphetamine, Valium, LSD, and inhalants). For each drug type, arrestees reported whether they had ever used the drug, age of first use, whether they had used the drug in the past 30 days and past 72 hours, number of days they used the drug in past month, whether they tried to cut down or quit using the drug, if they were successful, whether they felt dependent on the drug, whether they were receiving treatment for the drug, whether they had received treatment for the drug in the past, and whether they thought they could use treatment for that drug. Additional variables include whether juvenile respondents had ever injected drugs, whether they were influenced by drugs when they allegedly committed the crime for which they were arrested, whether they had been to an emergency room for drug-related incidents, and if so, whether in the past 12 months, and information on arrests and charges in the past 12 months. As with the adult data, urine test results are also provided. Finally, variables covering precinct (precinct of arrest) and law (penal law code associated with the crime for which the juvenile was arrested) are also provided for use by local law enforcement officials at each site.
Curated

Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2001 (ICPSR 3688)

Released/updated on: 2006-03-30
Geographic coverage: North Carolina, Oklahoma City, Detroit, Charlotte, Indiana, Tucson, Albuquerque, Spokane, Utah, San Jose, New York City, San Diego, Arizona, Las Vegas, Sacramento, Seattle, California, Pennsylvania, Tulsa, Laredo, Iowa, Illinois, Texas, Portland (Oregon), Indianapolis, Oregon, United States, Oklahoma, Alabama, Cleveland, Washington, Nebraska, Albany (New York), Omaha, Minneapolis, Colorado, Honolulu, Missouri, New Orleans, Alaska, Phoenix, Denver, Salt Lake City, Dallas, Nevada, Des Moines, San Antonio, Chicago, Hawaii, Minnesota, Kansas City (Missouri), New York (state), Birmingham, Michigan, New Mexico, Louisiana, Anchorage, Ohio, Philadelphia
Time period: 2001-01-01--2001-12-31
The goal of the Arrestee Drug Abuse Monitoring (ADAM) Program is to determine the extent and correlates of illicit drug use in the population of booked arrestees in local areas. Data were collected in 2001 at four separate times (quarterly) during the year in 33 metropolitan areas in the United States. The ADAM program adopted a new instrument in 2000 in adult booking facilities for male (Part 1) and female (Part 2) arrestees. Data from arrestees in juvenile detention facilities (Part 3) continued to use the juvenile instrument from previous years, extending back through the DRUG USE FORECASTING series (ICPSR 9477). The ADAM program in 2001 also continued the use of probability-based sampling for male arrestees in adult facilities, which was initiated in 2000. Therefore, the male adult sample includes weights, generated through post-sampling stratification of the data. For the adult files, variables fell into one of eight categories: (1) demographic data on each arrestee, (2) ADAM facesheet (records-based) data, (3) data on disposition of the case, including accession to a verbal consent script, (4) calendar of admissions to substance abuse and mental health treatment programs, (5) data on alcohol and drug use, abuse, and dependence (6) drug acquisition data covering the five most commonly used illicit drugs, (7) urine test results, and (8) weights. The juvenile file contains demographic variables and arrestee's self-reported past and continued use of 15 drugs, as well as other drug-related behaviors.
Curated

Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2002 (ICPSR 3815)

Released/updated on: 2006-03-30
Geographic coverage: North Carolina, Oklahoma City, Charlotte, Indiana, Tucson, Albuquerque, Spokane, Utah, San Jose, New York City, San Diego, Arizona, Las Vegas, Sacramento, Seattle, California, Washington, District of Columbia, Pennsylvania, Tulsa, Laredo, Iowa, Illinois, Texas, Portland (Oregon), Georgia, Indianapolis, Oregon, United States, Oklahoma, Rio Arriba, Alabama, Cleveland, Washington, Nebraska, Albany (New York), Omaha, Minneapolis, Woodbury, Atlanta, Colorado, Honolulu, New Orleans, Alaska, Phoenix, Denver, Salt Lake City, Dallas, Nevada, Des Moines, San Antonio, Chicago, Hawaii, Minnesota, New York (state), Birmingham, New Mexico, Louisiana, Anchorage, Ohio, Los Angeles, Philadelphia
Time period: 2002-01-01--2002-12-31
The goal of the Arrestee Drug Abuse Monitoring (ADAM) Program is to determine the extent and correlates of illicit drug use in the population of booked arrestees in local areas. Data were collected in 2002 at four separate times (quarterly) during the year in 36 metropolitan areas in the United States. The ADAM program adopted a new instrument in 2000 in adult booking facilities for male (Part 1) and female (Part 2) arrestees. Data from arrestees in juvenile detention facilities (Part 3) continued to use the juvenile instrument from previous years, extending back through the DRUG USE FORECASTING series (ICPSR 9477). The ADAM program in 2002 also continued the use of probability-based sampling for male arrestees in adult facilities, which was initiated in 2000. Therefore, the male adult sample includes weights, generated through post-sampling stratification of the data. For the adult files, variables fell into one of eight categories: (1) demographic data on each arrestee, (2) ADAM facesheet (records-based) data, (3) data on disposition of the case, including accession to a verbal consent script, (4) calendar of admissions to substance abuse and mental health treatment programs, (5) data on alcohol and drug use, abuse, and dependence, (6) drug acquisition data covering the five most commonly used illicit drugs, (7) urine test results, and (8) weights. The juvenile file contains demographic variables and arrestee's self-reported past and continued use of 15 drugs, as well as other drug-related behaviors.
Curated

Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2003 (ICPSR 4020)

Released/updated on: 2006-03-30
Geographic coverage: North Carolina, Oklahoma City, Charlotte, Indiana, Tucson, Albuquerque, Spokane, Utah, San Jose, New York City, San Diego, Arizona, Las Vegas, Boston, Sacramento, Seattle, California, Florida, Pennsylvania, Tulsa, Iowa, Illinois, Texas, Portland (Oregon), Georgia, Tampa, Indianapolis, Oregon, United States, Oklahoma, Rio Arriba, Alabama, Cleveland, Washington, Nebraska, Albany (New York), Omaha, Minneapolis, Woodbury, Atlanta, Massachusetts, Colorado, Honolulu, New Orleans, Alaska, Phoenix, Denver, Salt Lake City, Dallas, Nevada, Des Moines, District of Columbia, San Antonio, Chicago, Hawaii, Minnesota, New York (state), Birmingham, Miami, New Mexico, Louisiana, Anchorage, Ohio, Los Angeles, Philadelphia, Houston
Time period: 2003-01-01--2003-12-31
The goal of the Arrestee Drug Abuse Monitoring (ADAM) Program is to determine the extent and correlates of illicit drug use in the population of booked arrestees in local areas. Data were collected in 2003 up to four separate times (quarterly) during the year in 39 metropolitan areas in the United States. The ADAM program adopted a new instrument in 2000 in adult booking facilities for male (Part 1) and female (Part 2) arrestees. The ADAM program in 2003 also continued the use of probability-based sampling for male arrestees in adult facilities, which was initiated in 2000. Therefore, the male adult sample includes weights, generated through post-sampling stratification of the data. For the adult male and female files, variables fell into one of eight categories: (1) demographic data on each arrestee, (2) ADAM facesheet (records-based) data, (3) data on disposition of the case, including accession to a verbal consent script, (4) calendar of admissions to substance abuse and mental health treatment programs, (5) data on alcohol and drug use, abuse, and dependence, (6) drug acquisition data covering the five most commonly used illicit drugs, (7) urine test results, and (8) for males, weights.
Curated

Arrestee Drug Abuse Monitoring (ADAM) Project in Rural Nebraska, 1998 (ICPSR 28141)

Released/updated on: 2011-01-28
Geographic coverage: Omaha, United States, Nebraska
Time period: 1998-10-01--1998-11-01
A pilot outreach project of the National Intstitute of Justice's Arrestee Drug Abuse Monitoring (ADAM) program, the rural Nebraska ADAM program examined the prevalence and type of arrestee drug use in four rural Nebraska counties and compared the results to those found in Omaha, Nebraska, an established ADAM site. The data were collected in Madison (n=78), Dawson (n=50), Hall (n=53), and Scotts Bluff (n=149) counties, and Omaha, Nebraska, (n=202) in October and November of 1998. The catchment area for Omaha was the central city. The ADAM interview provided demographic and descriptive data, including race, age, marital status, source of income, screens of substance abuse and dependency, treatment history, arrest and incarceration experiences, and participation in local drug markets. At the conclusion of the interview, respondents were asked to provide a urine specimen. The current study included a supplemental questionnaire about methamphetamine use. The methamphetamine addendum included variables on why the respondent began and continued the use of methamphetamines, how often and how much methamphetamine was used, if and why the respondent had ever sought and completed treatment, source of the methamphetamine, and if the respondent had ever made or sold methamphetamine.
Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2009 (ICPSR 30061)

Released/updated on: 2011-02-24
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 7,794 arrestees were interviewed during the second and third quarters of 2009. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2009, and ending September 30, 2009. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2010 (ICPSR 32321)

Released/updated on: 2011-11-04
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 8,332 arrestees were interviewed during the second and third quarters of 2010. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2010, and ending September 30, 2010. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated

California Drug and Alcohol Treatment Assessment (CALDATA), 1991-1993 (ICPSR 2295)

Released/updated on: 2008-10-07
Geographic coverage: United States, California
Time period: 1991-01-01--1993-01-01
The California Drug and Alcohol Treatment Assessment (CALDATA) was designed to study the costs, benefits, and effectiveness of the state's alcohol and drug treatment infrastructure (recovery services) and specifically to assess (1) the effects of treatment on participant behavior, (2) the costs of treatment, and (3) the economic value of treatment to society. Data were collected on participants (clients) across four types of treatment programs, or modalities: residential, residential "social model," nonmethadone outpatient, and outpatient methadone (detoxification and maintenance). Data were collected in two phases. In Phase 1, treatment records were abstracted for clients who received treatment or were discharged between October 1, 1991, and September 30, 1992. In Phase 2, these clients were located and recruited for a follow-up interview. The CALDATA design and procedures included elements from several national treatment outcome studies including the Drug Services Research Survey (ICPSR 3393), Services Research Outcomes Study (ICPSR 2691), National Treatment Improvement Evaluation Study (ICPSR 2884), and Drug Abuse Treatment Outcome Study (ICPSR 2258). The record abstract was designed to collect identifying and locating information for interview reference during the personal interviewing phase. The abstract also collected demographic, drug, or alcohol use, and treatment and service information. The follow-up questionnaire covered time periods before, during, and after treatment and focused on topics such as ethnic and educational background, drug and alcohol use, mental and physical health, HIV and AIDS status, drug testing, illegal activities and criminal status, living arrangements and family issues, employment and income, and treatment for drug, alcohol, and mental health problems. Drugs included alcohol, barbiturates, benzodiazepines, cocaine powder, crack, downers, hallucinogens, heroin, illegal methadone, inhalants, LSD, marijuana/hashish/THC, methamphetamines and other stimulants, narcotics, over-the-counter drugs, PCP, ritalin or preludin, and sedatives/hypnotics. CALDATA was originally known as the California Outcomes Study (COS).
Curated

Crack, Powder Cocaine, and Heroin: Drug Purchase and Use Patterns in Six Cities in the United States, 1995-1996 (ICPSR 2564)

Released/updated on: 2012-08-22
Geographic coverage: New York City, Oregon, District of Columbia, San Diego, San Antonio, United States, Chicago, Illinois, Texas, Portland (Oregon), California, New York (state)
Time period: 1995-01-01--1996-01-01
This study was designed to address the practical and policy implications of various drug market participation patterns. In 1995, the Office of National Drug Control Policy (ONDCP) and the National Institute of Justice (NIJ) collaborated on a project called the Procurement Study. This study was executed as an addendum to NIJ's Drug Use Forecasting (DUF) program (DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 [ICPSR 9477]) with the goal of extending previous research in which heroin users were interviewed on various aspects of drug market activity. The present study sought to explore additional features of drug market participation and use, both within and across drug types and cities, and included two additional drugs -- powder cocaine and crack cocaine. Data were collected from recently arrested users of powder cocaine, crack cocaine, and heroin in six DUF cities (Chicago, New York, Portland, San Diego, San Antonio, and Washington, DC). Each of the three files in this collection, Crack Data (Part 1), Heroin Data (Part 2), and Powder Cocaine Data (Part 3), is comprised of data from a procurement interview, urine test variables, and a DUF interview. During the procurement interview, information was collected on purchase and use patterns for specific drugs. Variables from the procurement interview include the respondent's method of using the drug, the term used to refer to the drug, whether the respondent bought the drug in the neighborhood, the number of different dealers the respondent bought the drug from, how the respondent made the connection with the dealer (i.e., street, house, phone, beeper, business/store, or friends), their main drug source, whether the respondent went to someone else if the source was not available, how the respondent coped with not being able to find drugs to buy, whether the respondent got the drug for free, the means by which the respondent obtained money, the quantity and packaging of the drug, and the number of minutes spent searching for, traveling to, and waiting for their last purchase. Urine tests screened for the presence of ten drugs, including marijuana, opiates, cocaine, PCP, methadone, benzodiazepines (Valium), methaqualone, propoxyphene (Darvon), barbiturates, and amphetamines (positive test results for amphetamines were confirmed by gas chromatography). Data from the DUF interview provide detailed information about each arrestee's self-reported use of 15 drugs. For each drug type, arrestees were asked whether they had ever used the drug, the age at which they first used the drug, whether they had used the drug within the past three days, how many days they had used the drug within the past month, whether they had ever needed or felt dependent on the drug, and whether they were dependent on the drug at the time of the interview. Data from the DUF interview instrument also included alcohol/drug treatment history, information about whether arrestees had ever injected drugs, and whether they were influenced by drugs when the crime that they were charged with was committed. The data also include information about whether the arrestee had been to an emergency room for drug-related incidents and whether he or she had had prior arrests in the past 12 months. Demographic data include the age, race, sex, educational attainment, marital status, employment status, and living circumstances of each respondent.
Curated
Simple Crosstabs

Criminal Justice Drug Abuse Treatment Studies 2: Medication-Assisted Therapy, 2010-2013 [United States] (ICPSR 34988)

Released/updated on: 2016-02-02
Geographic coverage: Rhode Island, Puerto Rico, United States, Texas, Connecticut, Kentucky, California, Delaware, Maryland, Arizona, Pennsylvania
Time period: 2010-01-01--2013-01-01

The Criminal Justice Drug Abuse Treatment Studies 2 (CJ-DATS 2) was launched in 2008 with a focus on conducting implementation research in criminal justice settings. NIDA's ultimate goal for CJ-DATS 2 was to identify implementation strategies that maximize the likelihood of sustained delivery of evidence-based practices to improve offender drug abuse and HIV outcomes, and to decrease their risk of incarceration.

The Medication-Assisted Therapy (MAT) study focuses on implementing linkages to medication assisted treatment in correctional settings. During the study period community corrections staff engaged in training about addiction pharmacotherapies, while leadership in the corrections and treatment facilities engage in a joint strategic planning process to identify and resolve barriers to efficient flow of clients across the two systems.

This study includes 28 datasets and over 1,400 variables. The first five datasets for this study contain data on the baseline characteristics of the treatment and corrections sites that participated in the study as well as the characteristics of the staff working at those facilities. Opinions about Medication Assisted Treatment surveys were administered to personnel at the participating corrections and treatment sites (D6). Data on Inter-organization Relations between Probation and Parole staff with Treatment Providers were also collected (DS7-DS18).

Information was extracted from the charts of clients about their alcohol and opioid dependence as well as the referrals and treatment the clients received (DS19). Probation and parole officers and treatment providers were surveyed about monthly counts of referrals (DS20-DS21).

During the study 10 staff members from the community corrections agency and local treatment providers where MAT services were available were nominated to participate in a Pharmacotherapy Exchange Council (PEC). PEC members were involved with strategic planning for implementing changes to improve the usage of Medication-Assisted Therapy. PEC members were surveyed several times throughout the study.

PEC members completed surveys on how well the sites were adhering to the Organizational Linkages Intervention (OLI) process (DS22). Community corrections staff, PEC members and Connections Coordinators in the experimental group were surveyed about their perceptions of organizational benefits and costs associated with the MATICCE intervention (DS23). The PEC rated the Connections Coordinators (DS24)and the Connections Coordinators rate the PEC (DS25). PEC researchers completed surveys on how much of the OLI was completed (DS26) as well as what the sustainability of the changes made through the MATTICE project (DS27). The final dataset provides a key for who took the KPI (Key Performance Indicators) training and who was a PEC member (DS28).

Curated
Simple Crosstabs

Development and Malleability from Childhood to Adulthood in Baltimore, Maryland, 2001-2005 (ICPSR 34870)

Released/updated on: 2015-04-27
Geographic coverage: Baltimore, United States, Maryland
Time period: 2001-01-01--2005-01-01

In the fall of 1993, the entering 1st graders in nine Baltimore City, Maryland public elementary schools were recruited for participation in a randomized trial of two universal, preventive interventions. Both interventions targeted the early antecedent risk behaviors of poor academic achievement and aggressive/coercive behavior and their distal correlates: substance abuse/dependence, antisocial behavior, high risk sexual behavior, sexually transmitted infections (STIs), and psychiatric symptoms and disorders. One intervention, the classroom-centered intervention (CC), sought to reduce the early risk behaviors of poor achievement and aggressive/coercive behaviors through the enhancement of classroom curricula and teacher instructional and behavior management practices. The second intervention, the family-school partnership intervention (FSP), sought to reduce these early risk behaviors by improving parent-teacher/school mental health professional collaboration and by enhancing parents' teaching and behavior management skills. The participating students and 1st grade teachers were randomly assigned to either the CC or FSP classroom-level conditions or to a control or standard setting classroom. The participating students' outcomes were assessed from the fall of 1st grade through 12th grade. Annual outcome assessments continued following high school through age ~ 26. Data from participating students' self-report of substance use and its putative mediators and moderators in 8th through 12th grade are available in this dataset.

The principal investigator withheld the intervention status variable that distinguishes the intervention groups from the control group. You may contact the Principal investigator to discuss obtaining the intervention variable.

This dataset contains variables on frequency of respondents' substance use during the respondents' lifetime as well as in the year, month, week prior to the survey. In addition, the dataset contains variables on alcohol consumption. The dataset also contains variables on the respondents' perceptions of the availability and harmfulness of substances. Respondents were also asked about perception of how many of his/her friends used drugs as well as their attitudes towards drug use, including personal disapproval of drug use, and perceived attitudes of parents and friends towards the respondents' drug use. Respondents were asked whether and how often they were offered substances to use and their intention to use substances if offered in the future. Substances asked about include tobacco, alcohol, marijuana, cocaine, crack, heroin, ecstasy, and inhalants.

This dataset contains 1535 variables and 713 respondents. The only demographic variables in this dataset are race and gender.

Curated
Simple Crosstabs

Flint [Michigan] Adolescent Study (FAS): A Longitudinal Follow-Up Study of Substance Use on Adult Transitional Events, 2000-2003 (ICPSR 37032)

Released/updated on: 2018-07-30
Geographic coverage: Flint, United States, Michigan
Time period: 2000-01-01--2003-01-01

The Flint [Michigan] Adolescent Study (FAS): A Longitudinal Follow-Up Study of Substance Use on Adult Transitional Events, 2000-2003 collection includes data collected as part of four follow-up waves conducted for the Flint Adolescent Study (FAS). These data are waves five through eight, the original four waves can be found in ICPSR study 34598 (Flint [Michigan] Adolescent Study (FAS): A Longitudinal Study of School Dropout and Substance Use, 1994-1997.)

The Flint Adolescent Study (FAS) originally interviewed 850 ninth graders in the four public high schools of Flint, MI, between 1994 and 1997. Follow-up wave interviews were conducted four years after high school, between 2000 and 2003, as participants transitioned to young adulthood. The study was conducted in collaboration with the projects of Urban and Regional Affairs and Flint Community Schools. The goal of the study was to explore the protective factors associated with school dropout and alcohol and substance use. The study followed the youths for four years beginning in the Fall of 1994 to gather the first four waves of the study. The sample reflected the overall student body in the Flint high schools. In order to study those students most at risk for leaving school before graduation, individuals with grade point averages of 3.0 and below were selected.

Interviews were conducted face-to-face with each participant in a community location. Each interview took about one hour to complete. At the end of the interview students were asked to complete the last section of the questionnaire containing questions about their drug use and sexual behavior by themselves.

Information obtained from the participants include: participation in church and community organizations; social support and influence of family and friends; self-esteem and psychological wellbeing; delinquent and violent behaviors; alcohol and substance use; sexual behavior and child bearing; school attitudes and performance; and family structure and relationships. Many items included in the follow-up waves repeat those present in the original surveys. Questions were also asked about driving behavior, stress, and racial identity. Data was also collected about participant education and occupation.

Demographic variables in this collection include age, sex, race, education, occupation, employment history, residence type, household composition, height and weight, marital status, and number of children.

Curated

Gender, Mental Illness, and Crime in the United States, 2004 (ICPSR 27521)

Released/updated on: 2011-02-10
Geographic coverage: United States
The purpose of the study was to examine the gendered effects of depression, drug use, and treatment on crime and the effects of interaction with the criminal justice system on subsequent depression and drug use. The data for the study are from the NATIONAL HOUSEHOLD SURVEY ON DRUG USE AND HEALTH (NSDUH), 2004 [ICPSR 4373]. In addition to the 2004 NSDUH data, the study utilized new variables that were derived from the original dataset by the principal investigator, namely recoded variables, interaction variables, and computed indices. Information was provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 years and older. Respondents also provided detailed information regarding criminal activity, depression, and other factors. A total of 55,602 respondents participated in the study. The dataset contains a total of 3,011 variables. The first 2,690 variables are drawn from the 2004 NSDUH dataset and the remaining 321 variables were created by the principal investigator. Variables created by the principal investigator are manipulations of the first 2,690 variables. Specifically, these variables include depression indices, drug dependence indicators, interactions with gender and other demographic variables, and dichotomous recoded variables relating to types of drug abuse and criminal behavior.
Curated

The Historically Black College and University Campus Sexual Assault (HBCU-CSA) Study, 2008 (ICPSR 31301)

Released/updated on: 2013-12-03
Geographic coverage: United States
The Historically Black College and University Campus Sexual Assault Study was undertaken to document the prevalence, personal and behavioral factors, context, consequences, and reporting of distinct forms of sexual assault. This study examined campus police and service provider perspectives on sexual victimization and student attitudes toward law enforcement and ideas about prevention and policy. The HBCU-CSA Study was a web survey administered in the fall semester of 2008 at 4 different colleges and universities. The participants included 3,951 undergraduate women and 88 staff from campus police, counseling centers, student health services, office of judicial affairs, women's center, office of the dean of students, and residential life.
Curated
Partially restricted
Simple Crosstabs

Mindful Body Awareness Training for Medication for Opioid Use Disorder (MOUD), Pacific Northwest, 2019-2024 (ICPSR 39235)

Released/updated on: 2025-06-19
Geographic coverage: United States
Time period: 2019-08-01--2024-01-31
The national opioid epidemic requires development of real-world evidence-based treatments for opioid use disorder, including adjuncts to Medication for Opioid Use Disorder (MOUD). Interventions are needed that address the complex needs of patients with opioid use disorder, which include substantial mental health co-morbidity and high rates of chronic pain. This study tested a mind-body intervention, Mindful Awareness in Body-oriented Therapy (MABT), as an adjunct to MOUD across multiple community outpatient clinical settings. MABT, a mindfulness-based intervention, addresses aspects of awareness, interoception, and regulation that may be associated with pain, mental health distress, and behavioral control that increase risk of relapse and poor treatment outcomes.
Curated

Monitoring Drug Markets in Manhattan [New York City], With the Arrestee Drug Abuse Monitoring (ADAM) Program, 1998-2002 (ICPSR 22381)

Released/updated on: 2009-06-03
Geographic coverage: New York City, United States, New York (state)
Time period: 1998-01-01--2002-01-01
The purpose of the study was to determine how much Manhattan (New York City) arrestees surveyed by the Arrestee Drug Abuse Monitoring (ADAM) program spend on drug expenses. The program obtained both self-report and urinalysis data from a total of 5,210 Manhattan arrestees surveyed by the ADAM program from 1998 to 2002. The principal investigators developed a formula for an episodic estimator of a respondent's drug expense for cash, noncash, and cash-combination transactions. The dataset contains a total of 267 variables relating to Manhattan arrestees' demographics, interview information, criminal history, urinalysis test results, drug use, drug market transactions, and drug expenses.
Curated

Monitoring the Future: Base Year & Follow-Up Core Panel Data, Ages 18-30, United States, 1976-2021 [Restricted-Use] (ICPSR 39223)

Released/updated on: 2025-07-02
Geographic coverage: United States
Time period: 1976-01-01--2021-01-01

The Monitoring the Future (MTF) project is a long-term epidemiologic and etiologic study of substance use among youth and adults in the United States. It is conducted at the University of Michigan's Institute for Social Research and is funded by a series of investigator-initiated research grants from the National Institute on Drug Abuse.

The MTF panel study consists of six different survey forms (five forms from 1976-1988), and each survey contains a "core" set of questions about demographics and substance use. This study contains the "core" data for these questions compiled across all survey forms and years in which they are included for the longitudinal panel participants. Each record in the core panel dataset includes the respondent's data for their base year (BY) 12th grade survey (modal age 18) and their young adult follow-up FU surveys (modal ages 19-30).

The core panel dataset should be selected by all researchers. Use the linking variable available on all datasets, MTFID, to link the core dataset with all other MTF panel datasets.

Here is a list of subjects included in the core dataset:

Administrative variables

  • Year of administration
  • Survey form
  • Survey date
  • BY survey weight, sampling stratum and cluster
  • FU panel analysis weights

Demographics

BY only

  • #Parents in household
  • Parent education levels
  • Respondent's age in months
  • Sex
  • Race/Ethnicity
  • Region of the country (school location)
  • Population density/Urbanicity (school location)
  • High school Zip Code, State and County FIPS codes (can be linked to user-provided data; results can be reported at no unit smaller than US geographical region)
  • Absenteeism (illness, cutting, skipping class)
  • High school program, Grades, post-high school plans

FU only

  • Pregnancy status
  • Household type
  • Urbanicity
  • Absenteeism (missing work due to illness, other)
  • Vocational/Technical education, Armed forces, College attendance
  • College grades, attendance, Greek life

BY and FU

  • Marital status
  • Household composition
  • Political preference
  • Religious attendance, importance, preference
  • Evenings out, Dating
  • Employment
  • Salary/earned Income and Other Income
  • Driving, tickets, and accidents related to alcohol and other substance use

Substance use

  • Cigarette use
  • Alcohol use (including binge drinking (e.g. 5+ drinks in a row/2 weeks), drunkenness)
  • Marijuana/cannabis, hashish use
  • LSD use
  • Hallucinogen use, other than LSD
  • Cocaine use (including cocaine, crack, other forms)
  • Amphetamine use
  • Sedatives/Barbiturate use
  • Tranquilizer use
  • Heroin use (with and without needles)
  • Narcotics use (other than Heroin)
  • Inhalant use
  • Steroid use
  • Ice use
  • Methamphetamine use
  • MDMA use
  • Vaping: nicotine, marijuana, flavoring

Please see the study documentation available on the MTF Panel series page for question-specific details.

More information about the MTF project can be accessed through the Monitoring the Future website. Annual reports are published by the research team, describing the data collection and trends over time.

Curated

Monitoring the Future: Base Year & Follow-Up Form 1 Panel Data, Ages 18-30, United States, 1976-2021 [Restricted-Use] (ICPSR 39282)

Released/updated on: 2025-03-20
Geographic coverage: United States
Time period: 1976-01-01--2021-01-01

The MTF study consists of six different survey forms (five forms from 1976-1988). This study contains the data for Form 1 longitudinal panel participants. The MTF Form 1 Panel dataset includes data for the base year (BY) 12th grade surveys (modal age 18) and their young adult follow-up FU surveys (modal ages 19-30).

In addition to demographic-related questions and questions about lifetime, annual, and 30-day substance use that are included on all survey forms, Form 1 also includes questions covering:

  • incidence of first use
  • co-use of substances
  • sources of obtaining substances
  • perceived friends' use
  • perceived availability of substances
  • when, where, and with who substance use is occurring
  • modes of substance use administration
  • reasons for use or non-use
  • own attitudes about substance use
  • perceived risk of use
  • substance use advertising
  • sources of help and treatment
  • free time and activities
  • role of citizens in government, confidence in government
  • voting and political activism
  • attitudes towards discrimination
  • satisfaction with life domains
  • healthy behaviors
  • physical health symptoms

Please see the study documentation available on the MTF Panel series page for question-specific details.

More information about the MTF project can be accessed through the Monitoring the Future website. Annual reports are published by the research team, describing the data collection and trends over time.

Curated

Monitoring the Future: Base Year & Follow-Up Form 2 Panel Data, Ages 18-30, United States, 1976-2021 [Restricted-Use] (ICPSR 39325)

Released/updated on: 2025-05-01
Geographic coverage: United States
Time period: 1976-01-01--2021-01-01

The MTF study consists of six different survey forms (five forms from 1976-1988). This study contains the data for Form 2 longitudinal panel participants. The MTF Form 2 restricted panel dataset includes data for the base year (BY) 12th grade surveys (modal age 18) and their young adult follow-up FU surveys (modal ages 19-30).

In addition to demographic-related questions and questions about lifetime, annual, and 30-day substance use that are included on all survey forms, Form 2 also includes questions covering:

  • Availability of drugs
  • Confidence/trust in government
  • Dating, marriage, and family
  • Delinquency and victimization
  • Expected future substance use
  • Exposure to substance use
  • Healthy behaviors, illness, COVID-19
  • Leisure time activities, high school and post-high school
  • Methods of marijuana use
  • Military: plans for service, draft opinion
  • Own attitudes and perceptions about substance use
  • Perceived friends' substance use
  • Perceived risk of substance use
  • Psychosocial domains: boredom, loneliness, self-esteem, depressive affect, social support, self-efficacy, risk taking
  • Satisfaction with life domains
  • Sources of help and treatment for substance use
  • Sources of marijuana
  • Substance use initiation
  • Vaping, including nicotine, marijuana, flavoring, sources
  • Voting, political activism

NOTE: In 2020, school-based data collection was halted due to COVID-19. BY sample sizes were affected, and data for some questions on forms 2 and 3 were suppressed. The list of variables affected is found in the 2020 12th grade Codebook available through NAHDAP.

Please see the study documentation available on the MTF Panel series page for question-specific details , including content areas included in all survey forms.

NOTE: Researchers are encouraged to begin their work with the "core" data file, NAHDAP study 39223. Please see the User's Guide, IV. Working with the MTF Restricted Panel Data, for details.

More information about the MTF project can be accessed through the Monitoring the Future website. Annual reports are published by the MTF research team, describing the data collection and trends over time.

Curated

Monitoring the Future: Base Year & Follow-Up Form 4 Panel Data, Ages 18-30, United States, 1976-2021 [Restricted-Use] (ICPSR 39326)

Released/updated on: 2025-06-16
Geographic coverage: United States
Time period: 1976-01-01--2021-01-01

The MTF study consists of six different survey forms (five forms from 1976-1988). This study contains the data for Form 4 longitudinal panel participants. The MTF Form 4 restricted panel dataset includes data for the base year (BY) 12th grade surveys (modal age 18) and their young adult follow-up FU surveys (modal ages 19-30).

In addition to demographic-related questions and questions about lifetime, annual, and 30-day substance use that are included on all survey forms, Form 4 also includes questions covering:

  • Beer, Wine, hard liquor, wine coolers use
  • Vaping sources
  • Flavored, small, and large cigars
  • Hookah, dissolvable tobacco, snus, and smokeless tobacco use
  • Own attitudes and perceptions about substance use
  • Perceived risk of substance use
  • Perceived friends' substance use
  • Perceived addictiveness of substances
  • Legal Issues Regarding Drugs
  • Delinquency, victimization, and feeling safe at school
  • Vocational plans, aspirations, expectations
  • Preferences regarding job characteristics
  • Desirability of different working arrangements and settings
  • Work ethic/success orientation
  • Dating and marriage: status, attitudes, expectations
  • Parenthood: attitudes, expectations
  • Values surrounding marriage and family
  • Personal materialism
  • Ecological concerns, conservation of resources
  • Attitudes toward governmental policies and practices
  • Local and global concerns
  • Voting behavior
  • Attitudes toward the military as an institution and occupation
  • Happiness; satisfaction with life domains and self

Please see the study documentation available on the MTF Panel series page for question-specific details.

More information about the MTF project can be accessed through the Monitoring the Future website. Annual reports are published by the research team, describing the data collection and trends over time.

Curated

Monitoring the Future: Base Year & Follow-Up Form 5 Panel Data, Ages 18-30, United States, 1976-2021 [Restricted-Use] (ICPSR 39283)

Released/updated on: 2025-03-20
Geographic coverage: United States
Time period: 1976-01-01--2021-01-01

The MTF study consists of six different survey forms (five forms from 1976-1988). This study contains the data for Form 5 longitudinal panel participants. The MTF Form 5 restricted panel dataset includes data for the base year (BY) 12th grade surveys (modal age 18) and their young adult follow-up FU surveys (modal ages 19-30).

In addition to demographic-related questions and questions about lifetime, annual, and 30-day substance use that are included on all survey forms, Form 5 also includes questions covering:

  • Non-prescription substance use, including Ritalin, Adderall, Oxycontin, Vicodin, fentanyl
  • Energy drinks/shots
  • Flavored alcohol, alcohol+caffeine
  • Flavored small and large cigars
  • Hookah
  • dissolvable tobacco, snus, smokeless tobacco
  • Synthetic marijuana use
  • Incidence of first use
  • Perceived risk of substance use
  • Own and others' attitudes and perceptions about substance use
  • Exposure to substance use
  • Substance use problems
  • Reasons for substance use, abstention or stopping use
  • Perceived availability of substances
  • Expected future substance use
  • Sources of help and treatment for substance use
  • Job-related substance use testing
  • Methods of substance use
  • Satisfaction with life domains
  • Interpersonal relationships
  • Parenthood: status, attitudes, expectations
  • Dating, marriage, and family: status, values, attitudes, expectations, sex roles
  • Military: plans for service, attitudes toward the military as an institution and occupation
  • Working arrangements and settings
  • Work ethic/success orientation
  • Leisure time: extent, activities, and attitudes
  • Community involvement
  • Voting and political activism
  • Political interest and preference
  • Concern for others, locally and globally
  • Conservation of resources, ecological concerns, mass transit
  • Attitudes towards discrimination
  • Expectations concerning societal change
  • Reactions to personal and social change
  • Personal materialism
  • Delinquency and victimization
  • Psychosocial domains: boredom, loneliness, self-esteem, depressive affect,social support, self-efficacy, risk taking
  • Healthy behaviors, illness, COVID-19
  • Post high school: status, plans, characteristics
  • High school sport involvement, concussion
  • Substance use education in high school

Please see the study documentation available on the MTF Panel series page for question-specific details, including content areas included in all survey forms.

More information about the MTF project can be accessed through the Monitoring the Future website. Annual reports are published by the research team, describing the data collection and trends over time.

Curated

Monitoring the Future: Restricted-Use Panel Data, United States, 1976-2019 (ICPSR 37072)

Released/updated on: 2023-03-27
Geographic coverage: United States
Time period: 1976-01-01--2019-01-01

The Monitoring the Future (MTF) project is a long-term epidemiologic and etiologic study of substance use among youth and adults in the United States. It is conducted at the University of Michigan's Institute for Social Research, and funded by a series of investigator-initiated research grants from the National Institute on Drug Abuse. MTF has two components: MTF Main and MTF Panel.

From its inception in 1975, the cross-sectional MTF Main study has collected data annually from nationally representative samples of 12,000-19,000 high school seniors in 12th grade located in approximately 135 schools nationwide. Beginning in 1991, similar annual cross-sectional surveys of nationally representative samples of 8th and 10th graders have been conducted. In all, approximately 45,000 students annually respond to about 100 drug use and demographic questions, as well as to about 200 additional questions divided among multiple survey forms on other topics such as attitudes toward government, social institutions, race relations, changing gender roles, educational aspirations, occupational aims, and marital plans.

The longitudinal MTF Panel study conducts follow-up surveys with representative subsamples of respondents from each 12th grade cohort participating in MTF Main. From each cohort, a sample of about 2,450 students are selected for longitudinal follow-up, with an oversampling of students who reported prior drug use during their 12th grade survey. Longitudinal follow-up currently spans modal ages 19-30 and 35-60. For surveys at modal ages 19-30, the sample is randomly split into two halves (approx. 1,225 each) to be followed every other year. One half-sample begins its first follow-up the year after high school (at modal age 19), and the other half-sample begins its first follow-up in the second year after high school (at modal age 20). Thus, six young adult follow-up (FU) surveys occur between modal ages 19-30, at modal ages 19/20 (FU1), 21/22 (FU2), 23/24 (FU3), 25/26 (FU4), 27/28 (FU5), and 29/30 (FU6). After age 30, respondents are surveyed every five years: 35, 40, 45, 50, 55, and 60 (these are referred to as FZ surveys). The FZ surveys cover many of the same topics as the 12th grade and FU surveys and include additional questions on life events and health.

MTF Panel surveys for the young adults (ages 19-30) were conducted using mailed paper surveys from 1977-2017. In 2018 and 2019, a random half of all those aged 19-30 received a mailed paper survey, while the other half were surveyed using a new procedure that encouraged participation using web surveys (web-push). The FZ surveys (ages 35-60) were conducted using mailed paper surveys through the 2019 data collection.

More information about the MTF project can be accessed through the Monitoring the Future website. Annual reports are published by the research team, describing the data collection and trends over time.

Curated

National Comorbidity Survey: Baseline (NCS-1), 1990-1992 (ICPSR 6693)

Released/updated on: 2008-09-12
Geographic coverage: United States
Time period: 1990-01-01--1992-01-01
The National Comorbidity Survey: Baseline (NCS-1) was a collaborative epidemiologic investigation designed to study the prevalence and correlates of DSM III-R disorders and patterns and correlates of service utilization for these disorders. The NCS-1 was the first survey to administer a structured psychiatric interview to a nationally representative sample. The survey was carried out in the early 1990s with a household sample of over 8,000 respondents. Subsamples of the original respondents completed the NCS-1 Part II survey and Tobacco Use Supplement. Diagnoses were based on a modified version of the Composite International Diagnostic Interview (the UM-CIDI), which was developed at the University of Michigan for the NCS-1. Drugs covered by this survey include alcohol, tobacco, sedatives, stimulants, tranquilizers, analgesics, inhalants, marijuana/hashish, cocaine, hallucinogens, heroin, nonmedical use of prescription drugs, and polysubstance use. Other items include demographic characteristics, personal and family history of substance use and abuse, substance abuse treatment, data on drug use including recency, frequency, and age at first use, problems resulting from the use of drugs, personal and family history of psychiatric problems, mental health treatment, symptoms of psychiatric disorders, mental health status, HIV risk behaviors, and physical health status.
Curated

National Comorbidity Survey: Baseline (NCS-1), 1990-1992 (Restricted Version) (ICPSR 25381)

Released/updated on: 2023-11-06
Geographic coverage: United States
Time period: 1990-01-01--1992-01-01
The National Comorbidity Survey: Baseline (NCS-1) is a collaborative epidemiologic investigation designed to study the prevalence and patterns of disorders in the third and revised edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM III-R) as well as correlates of service utilization for these disorders. The NCS-1 was the first survey to administer a structured psychiatric interview to a nationally representative sample and was carried out in the early 1990s with a household sample of over 8,000 respondents. Diagnoses were based on a modified version of the Composite International Diagnostic Interview (the UM-CIDI), which was developed at the University of Michigan for the NCS-1. This restricted-use data collection contains the following geographic variables that can be linked to the public-use version of the data using the CASEID variable: Census State FIPS codes, Census County FIPS codes, Census 5-Digit County-State FIPS codes, and Census 11-Digit State-County-Tract FIPS codes. However, in order to help preserve the confidentiality of the data the frequency tables in the codebook have been suppressed.
Curated
Simple Crosstabs

National Comorbidity Survey: Reinterview (NCS-2), 2001-2002 (ICPSR 35067)

Released/updated on: 2015-03-31
Geographic coverage: United States
Time period: 2001-01-01--2002-01-01

The NCS-2 was a re-interview of 5,001 individuals who participated in the Baseline (NCS-1). The study was conducted a decade after the initial baseline survey. The aim was to collect information about changes in mental disorders, substance use disorders, and the predictors and consequences of these changes over the ten years between the two surveys. The collection contains three major sections: the main survey, demographic data, and diagnostic data.

In the main survey, respondents were asked about general physical and mental health. Questions focused on a variety of health issues, including limitations caused by respondents' health issues, substance use, childhood health, life-threatening illnesses, chronic conditions, medications taken in the past 12 months, level of functioning and symptoms experienced in the past 30 days, and any services used by the respondents since the (NCS-1). Additional questions focused on mental disorders including depression, bipolar disorder, specific and social phobias, generalized anxiety, intermittent explosive disorder, suicidality, post-traumatic stress disorder, neurasthenia, pre-menstrual dysphoric disorder, attention deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and separation anxiety. Respondents were also asked about their lives in general, with topics including employment, finances, marriage, children, their social lives, and stressful life events experienced in the past 12 months. Additionally, two personality assessments were included consisting of respondents' opinions on whether various true/false statements accurately described their personalities. Another focus of the main survey dealt with substance use and abuse, nonmedical use of prescription drugs, and polysubstance use. Interview questions in the NCS-2 Main Survey were customized to each respondent based on previous responses in the Baseline (NCS-1).

The middle section contains demographic and other background information including age, education, employment, household composition, household income, marital status, and region.

The last section of the collection focused on whether respondents met diagnostic criteria for psychological disorders asked about in the main survey.

Curated

National Comorbidity Survey: Reinterview (NCS-2), 2001-2002 [Restricted-Use] (ICPSR 30921)

Released/updated on: 2024-03-04
Geographic coverage: United States
Time period: 2001-01-01--2002-01-01

The NCS-2 was a re-interview of 5,001 individuals who participated in the Baseline (NCS-1). The study was conducted a decade after the initial baseline survey. The aim was to collect information about changes in mental disorders, substance use disorders, and the predictors and consequences of these changes over the ten years between the two surveys. The collection contains four major sections: the main survey, demographic data, diagnostic data, and state, county, and tract FIPS data.

In the main survey, respondents were asked about general physical and mental health. Questions focused on a variety of health issues, including limitations caused by respondents' health issues, substance use, childhood health, life-threatening illnesses, chronic conditions, medications taken in the past 12 months, level of functioning and symptoms experienced in the past 30 days, and any services used by the respondents since the (NCS-1). Additional questions focused on mental disorders including depression, bipolar disorder, specific and social phobias, generalized anxiety, intermittent explosive disorder, suicidality, post-traumatic stress disorder, neurasthenia, pre-menstrual dysphoric disorder, attention deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and separation anxiety. Respondents were also asked about their lives in general, with topics including employment, finances, marriage, children, their social lives, and stressful life events experienced in the past 12 months. Additionally, two personality assessments were included consisting of respondents' opinions on whether various true/false statements accurately described their personalities. Another focus of the main survey dealt with substance use and abuse, nonmedical use of prescription drugs, and polysubstance use. Interview questions in the NCS-2 Main Survey were customized to each respondent based on previous responses in the Baseline (NCS-1).

The second part contains demographic and other background information including age, education, employment, household composition, household income, marital status, and region.

The third part focuses on whether respondents met diagnostic criteria for psychological disorders asked about in the main survey.

The fourth part contains respondents' state, county, and tract FIPS data.

Curated
Simple Crosstabs

National Crime Victimization Survey: School Crime Supplement, 2015 (ICPSR 36354)

Released/updated on: 2016-12-20
Geographic coverage: United States
The primary purpose of the School Crime Supplement (SCS) is to obtain additional information about school-related victimizations so that policymakers; academic researchers; practitioners at the federal, state, and local levels; and special interest groups who are concerned with crime in schools can make informed decisions concerning policies and programs. The SCS asks questions related to students' experiences with, and perceptions of crime and safety at school, including preventive measures employed by schools; students' participation in after school activities; students' perception of school rules and enforcement of these rules; the presence of weapons, drugs, alcohol, and gangs in school; student bullying; hate-related incidents; and attitudinal questions relating to the fear of victimization at school. These responses are linked to the National Crime Victimization Survey (NCVS) survey instrument responses for a more complete understanding of the individual student's circumstances.
Curated
Simple Crosstabs

National Crime Victimization Survey: School Crime Supplement, [United States], 2017 (ICPSR 36982)

Released/updated on: 2020-02-27
Geographic coverage: United States
The primary purpose of the School Crime Supplement (SCS) is to obtain additional information about school-related victimizations so that policymakers; academic researchers; practitioners at the federal, state, and local levels; and special interest groups who are concerned with crime in schools can make informed decisions concerning policies and programs. The SCS asks questions related to students' experiences with, and perceptions of crime and safety at school, including preventive measures employed by schools; students' participation in after school activities; students' perception of school rules and enforcement of these rules; the presence of weapons, drugs, alcohol, and gangs in school; student bullying; hate-related incidents; and attitudinal questions relating to the fear of victimization at school. These responses are linked to the National Crime Victimization Survey (NCVS) survey instrument responses for a more complete understanding of the individual student's circumstances.
Curated
Simple Crosstabs

National Crime Victimization Survey: School Crime Supplement, [United States], 2019 (ICPSR 37816)

Released/updated on: 2021-06-08
Geographic coverage: United States
The primary purpose of the School Crime Supplement (SCS) is to obtain additional information about school-related victimizations so that policymakers; academic researchers; practitioners at the federal, state, and local levels; and special interest groups who are concerned with crime in schools can make informed decisions concerning policies and programs. The SCS asks questions related to students' experiences with, and perceptions of crime and safety at school, including preventive measures employed by schools; students' participation in after school activities; students' perception of school rules and enforcement of these rules; the presence of weapons, drugs, alcohol, and gangs in school; student bullying; hate-related incidents; and attitudinal questions relating to the fear of victimization at school. These responses are linked to the National Crime Victimization Survey (NCVS) survey instrument responses for a more complete understanding of the individual student's circumstances.
Curated
Simple Crosstabs

National Crime Victimization Survey: School Crime Supplement, [United States], 2022 (ICPSR 38666)

Released/updated on: 2024-02-28
Geographic coverage: United States
The primary purpose of the School Crime Supplement (SCS) is to obtain additional information about school-related victimizations so that policymakers; academic researchers; practitioners at the federal, state, and local levels; and special interest groups who are concerned with crime in schools can make informed decisions concerning policies and programs. The SCS asks questions related to students' experiences with, and perceptions of crime and safety at school, including preventive measures employed by schools; students' participation in after school activities; students' perception of school rules and enforcement of these rules; the presence of weapons, drugs, alcohol, and gangs in school; student bullying; hate-related incidents; and attitudinal questions relating to the fear of victimization at school. These responses are linked to the National Crime Victimization Survey (NCVS) survey instrument responses for a more complete understanding of the individual student's circumstances.
Curated

National Household Survey on Drug Abuse, 1979 (ICPSR 6843)

Released/updated on: 2015-11-23
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, tobacco, and nonmedical use of prescription drugs among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine, hallucinogens, heroin, inhalants, alcohol, tobacco, nonmedical use of prescription drugs including psychotherapeutics, and polysubstance use. Respondents were also asked about their knowledge of drugs, perceptions of the risks involved, population movement, and sequencing of drug use. Fifty-seven percent of respondents were asked specific questions about their perceptions of the consequences of marijuana and alcohol use. The other 43 percent were asked about heroin use among friends. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, and household composition.
Curated

National Household Survey on Drug Abuse, 1982 (ICPSR 6845)

Released/updated on: 2015-11-23
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, tobacco, and nonmedical use of prescription drugs among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, and personal and family income sources and amounts. Half of the respondents were asked questions regarding substance use by close friends. Demographic data include gender, race, age, ethnicity, educational level, job status, income level, veteran status, household composition, and population density. Youth respondents were also asked about time spent on homework and leisure activities.
Curated

National Household Survey on Drug Abuse, 1985 (ICPSR 6844)

Released/updated on: 2015-11-23
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, tobacco, and nonmedical use of prescription drugs among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine, hallucinogens, heroin, inhalants, alcohol, tobacco, nonmedical use of prescription drugs including psychotherapeutics, and polysubstance use. Respondents were also asked about health conditions, substance abuse treatment history, problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, and personal and family income sources and amounts. Demographic data include gender, race, age, ethnicity, marital status, motor vehicle use, educational level, job status, income level, veteran status, past and current household composition, and population density.
Curated

National Household Survey on Drug Abuse, 1988 (ICPSR 9522)

Released/updated on: 2013-06-19
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density.
Curated

National Household Survey on Drug Abuse, 1990 (ICPSR 9833)

Released/updated on: 2013-05-06
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density.
Curated

National Household Survey on Drug Abuse, 1991 (ICPSR 6128)

Released/updated on: 2015-11-23
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Data are also provided on treatment for drug use and on illegal activities related to drug use. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density.
Curated

National Household Survey on Drug Abuse, 1992 (ICPSR 6887)

Released/updated on: 2013-05-06
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Data are also provided on treatment for drug use and on illegal activities related to drug use. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density.
Curated

National Household Survey on Drug Abuse, 1993 (ICPSR 6852)

Released/updated on: 2013-05-06
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Data are also provided on treatment for drug use and on illegal activities related to drug use. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density.
Curated

National Household Survey on Drug Abuse, 1994 (ICPSR 6949)

Released/updated on: 2013-06-20
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, anabolic steroids, nonmedical use of prescription-type psychotherapeutic drugs, and polysubstance use. Respondents were also asked about substance abuse treatment history, illegal activities, problems resulting from use of drugs, perceptions of the risks involved, and personal and family income sources and amounts. Questions on need for treatment for drug or alcohol use, criminal record, and needle-sharing were also included. A split sample design using two questionnaires was employed with the 1994 NHSDA. The 1994-A questionnaire is comparable to NHSDA questionnaires prior to 1994 and contains all of the core questions from previous NHSDAs. The 1994-B questionnaire, which includes new questions on access to care and mental health, incorporates significant changes from the previous questionnaires and can only be compared to NHSDA surveys in 1995 and beyond. The changes to the questionnaire were undertaken in order to facilitate respondent cooperation, enhance the clarity of questions, improve the accuracy of responses, and increase the reliability of measurements across survey years. In addition, a rural supplementary sample was included in 1994 to obtain substance abuse prevalence estimates for rural areas. Demographic data include gender, race, age, ethnicity, marital status, motor vehicle use, educational level, job status, income level, veteran status, and past and current household composition.
Curated

National Household Survey on Drug Abuse, 1995 (ICPSR 6950)

Released/updated on: 2013-05-06
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, anabolic steroids, nonmedical use of prescription drugs including psychotherapeutics, and polysubstance use. Respondents were also asked about substance abuse treatment history, illegal activities, problems resulting from use of drugs, perceptions of the risks involved, personal and family income sources and amounts, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this administration of the survey. Demographic data include gender, race, age, ethnicity, marital status, motor vehicle use, educational level, job status, income level, veteran status, and past and current household composition.
Curated

National Household Survey on Drug Abuse, 1996 (ICPSR 2391)

Released/updated on: 2013-05-06
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about substance abuse treatment history, illegal activities, problems resulting from the use of drugs, personal and family income sources and amounts, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this administration of the survey. In 1996, the section on risk/availability of drugs was reintroduced, and sections on driving behavior and personal behavior were added. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, veteran status, and current household composition.
Curated

National Household Survey on Drug Abuse, 1997 (ICPSR 2755)

Released/updated on: 2013-05-06
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about substance abuse treatment history, illegal activities, problems resulting from the use of drugs, personal and family income sources and amounts, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this administration of the survey. In 1996, the section on risk/availability of drugs was reintroduced, and sections on driving behavior and personal behavior were added (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1996 [ICPSR 2391]). The 1997 questionnaire continued the risk/availability section along with new items about the use of cigars, people present when respondents used marijuana or cocaine for the first time (if applicable), reasons for using these two drugs the first time, reasons for using these two drugs in the past year, reasons for discontinuing use of these two drugs (for lifetime but not past-year users), and reasons respondents never used these two drugs. In addition, a new series of questions asked only of respondents aged 12 to 17 was introduced. These items covered a variety of topics that may be associated with substance use and related behaviors, such as exposure to substance abuse prevention and education programs, gang involvement, relationship with parents, and substance use by friends. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, veteran status, and current household composition.
Curated

National Household Survey on Drug Abuse, 1998 (ICPSR 2934)

Released/updated on: 2013-05-06
Geographic coverage: United States
The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about personal and family income sources and amounts, substance abuse treatment history, illegal activities, problems resulting from the use of drugs, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this administration of the survey. Also retained was the section on risk/availability of drugs that was reintroduced in 1996, and sections on driving behavior and personal behavior were added (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1996 [ICPSR 2391]). The 1997 questionnaire (NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1997 [ICPSR 2755]) introduced new items that the 1998 NHSDA continued on cigar smoking, people who were present when respondents used marijuana or cocaine for the first time (if applicable), reasons for using these two drugs the first time, reasons for using these two drugs in the past year, reasons for discontinuing use of these two drugs (for lifetime but not past-year users), and reasons respondents never used these two drugs. Both the 1997 and 1998 NHSDAs had a series of questions that were asked only of respondents aged 12 to 17. These items covered a variety of topics that may be associated with substance use and related behaviors, such as exposure to substance abuse prevention and education programs, gang involvement, relationship with parents, and substance use by friends. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, veteran status, and current household composition.
Curated

National Household Survey on Drug Abuse, 1999 (ICPSR 3239)

Released/updated on: 2013-06-25
Geographic coverage: United States
The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous NHSDA administrations were retained in the 1999 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving behavior and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated

National Household Survey on Drug Abuse, 2000 (ICPSR 3262)

Released/updated on: 2013-06-25
Geographic coverage: United States
The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous NHSDA administrations were retained in the 2000 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving behavior and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and retained in the 2000 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated

National Household Survey on Drug Abuse, 2001 (ICPSR 3580)

Released/updated on: 2013-06-25
Geographic coverage: United States
The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous NHSDA administrations were retained in the 2001 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving behavior and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and have been retained through the 2001 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. In addition, in 2001 questions on purchase of marijuana were added.
Curated
Partially restricted
Simple Crosstabs

National Social Life, Health, and Aging Project (NSHAP): Round 3 and COVID-19 Study, [United States], 2015-2016, 2020-2021 (ICPSR 36873)

Released/updated on: 2024-09-09
Geographic coverage: United States
Time period: 2015-01-01--2016-01-01, 2020-01-01--2021-01-01

The National Social Life, Health and Aging Project (NSHAP) is a population-based study of health and social factors on a national scale, aiming to understand the well-being of older, community-dwelling Americans by examining the interactions among physical health, illness, medication use, cognitive function, emotional health, sensory function, health behaviors, and social connectedness. It is designed to provide health providers, policy makers, and individuals with useful information and insights into these factors, particularly on social and intimate relationships.

The National Opinion Research Center (NORC), along with Principal Investigators at the University of Chicago, conducted more than 3,000 interviews during 2005 and 2006 with a nationally representative sample of adults aged 57 to 85. Face-to-face interviews and biomeasure collection took place in respondents' homes. Round 3 was conducted from September 2015 through November 2016, where 2,409 surviving Round 2 respondents were re-interviewed, and a New Cohort consisting of adults born between 1948 and 1965 together with their spouses or co-resident partners was added. All together, 4,777 respondents were interviewed in Round 3. The following files constitute Round 3: Core Data, Social Networks Data, Disposition of Returning Respondent Partner Data, and Proxy Data.

Included in the Core files (Datasets 1 and 2) are demographic characteristics, such as gender, age, education, race, and ethnicity. Other topics covered respondents' social networks, social and cultural activity, physical and mental health including cognition, well-being, illness, history of sexual and intimate partnerships and patient-physician communication, in addition to bereavement items. In addition data on a panel of biomeasures including, weight, waist circumference, height, and blood pressure was collected. The Social Networks (Datasets 3 and 4) files detail respondents' current relationship status with each person identified on the network roster. The Disposition of Returning Respondent Partner (Datasets 5 and 6) files detail information derived from Section 6A items regarding the partner from Rounds 1 and 2 within the questionnaire. This provides a complete history for respondent partners across both rounds. The Proxy (Datasets 7 and 8) files contain final health data for Round 1 and Round 2 respondents who could not participate in NSHAP due to disability or death.

The COVID-19 sub-study, administered to NSHAP R3 respondents in the Fall of 2020, was a brief self-report questionnaire that probed how the coronavirus pandemic changed older adults' lives. The COVID-19 sub-study questionnaire was limited to assessing specific domains in which respondents may have been affected by the coronavirus pandemic, including: (1) COVID experiences, (2) health and health care, (3) job and finances, (4) social support, (5) marital status and relationship quality, (6) social activity and engagement, (7) living arrangements, (8) household composition and size, (9) mental health, (10) elder mistreatment, (11) health behaviors, and (12) positive impacts of the coronavirus pandemic. Questions about engagement in racial justice issues since the death of George Floyd in police custody were also added to facilitate analysis of the independent and compounding effects of both the COVID-19 pandemic and reckoning with longstanding racial injustice in America.

Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2002 (ICPSR 3903)

Released/updated on: 2015-11-23
Geographic coverage: United States
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey includes questions concerning treatment for both substance abuse and mental health related disorders. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2002 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and have been retained through the 2002 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Back to top